Logo image
Vulvovaginal candidiasis
Journal article   Peer reviewed

Vulvovaginal candidiasis

Paul Nyirjesy and Jack D Sobel
Obstetrics and gynecology clinics of North America, v 30(4), pp 671-684
Dec 2003
PMID: 14719844

Abstract

Anti-Bacterial Agents - adverse effects Antifungal Agents - administration & dosage Antifungal Agents - therapeutic use Candidiasis, Vulvovaginal - diagnosis Candidiasis, Vulvovaginal - drug therapy Candidiasis, Vulvovaginal - etiology Diabetes Complications Diagnosis, Differential Estrogens - adverse effects Female Humans Immunosuppression Recurrence Sexual Behavior
VVC represents a spectrum of disease. Although there is a clear need for better use of diagnostic modalities and development of better treatment alternatives, most patients with VVC, even the complicated cases, at least have the perspective of achieving adequate control of their symptoms. Future advances, particularly in the area of home diagnostics, may help to optimize use of currently available medicines.

Metrics

14 Record Views
44 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Obstetrics & Gynecology
Logo image